日本新薬(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証PRM | 医薬品 | 4516/E00931 | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2022/01/07 | 日証協 | 725,765株 | -2.46% | 44,358株 | -68.01% | 606,570株 | +9.53% | 76,708株 | +0.72% |
2021/12/30 | 日証協 | 744,104株 | 0% | 138,665株 | 0% | 553,773株 | 0% | 76,160株 | 0% |
2021/12/24 | 日証協 | 744,104株 | +14.74% | 138,665株 | -18.59% | 553,773株 | +5.08% | 76,160株 | +16.07% |
2021/12/17 | 日証協 | 648,521株 | +11.74% | 170,324株 | -0.79% | 527,003株 | +3.07% | 65,618株 | -11.5% |
2021/12/10 | 日証協 | 580,361株 | +14.22% | 171,680株 | -4.74% | 511,288株 | -1.95% | 74,145株 | -52.79% |
2021/12/03 | 日証協 | 508,093株 | +9.34% | 180,226株 | +84.45% | 521,446株 | +14.38% | 157,045株 | +191.75% |
2021/11/26 | 日証協 | 464,706株 | -0.01% | 97,711株 | +29.25% | 455,904株 | +4.13% | 53,829株 | +124.06% |
2021/11/19 | 日証協 | 464,757株 | -5.77% | 75,599株 | -15.23% | 437,837株 | -1.79% | 24,024株 | +28.44% |
2021/11/05 | 日証協 | 461,141株 | -23.75% | 39,818株 | -88.57% | 444,263株 | -26.69% | 54,470株 | -73.64% |
2021/10/29 | 日証協 | 604,791株 | +8.64% | 348,390株 | -1.17% | 606,022株 | -0.2% | 206,653株 | +26.2% |
2021/10/22 | 日証協 | 556,685株 | -21.62% | 352,513株 | +7.04% | 607,211株 | -16.57% | 163,753株 | +59.72% |
2021/10/15 | 日証協 | 710,211株 | -7.23% | 329,315株 | -66.52% | 727,798株 | -19.28% | 102,527株 | -85.5% |
2021/10/08 | 日証協 | 765,592株 | +367.95% | 983,641株 | +390.15% | 901,625株 | +116.84% | 707,022株 | +239.55% |
2021/10/01 | 日証協 | 163,607株 | -35.27% | 200,683株 | -23.03% | 415,793株 | -6.07% | 208,224株 | +305.09% |
2021/09/24 | 日証協 | 252,753株 | -7.14% | 260,714株 | +4.99% | 442,656株 | -19.37% | 51,402株 | -88.38% |
2021/09/17 | 日証協 | 272,188株 | -51.76% | 248,323株 | +11.18% | 549,013株 | -13.58% | 442,311株 | +633.65% |
2021/09/10 | 日証協 | 564,201株 | -3.34% | 223,351株 | +60.33% | 635,257株 | -6.22% | 60,289株 | -55.34% |
2021/09/03 | 日証協 | 583,705株 | +4.89% | 139,306株 | -4.99% | 677,380株 | +15.73% | 134,989株 | +3.49% |
2021/08/27 | 日証協 | 556,489株 | -7.35% | 146,630株 | -45.02% | 585,304株 | -11.32% | 130,439株 | +19.38% |
※株式分割は考慮していませんのでご注意ください。
Page Top